Consequently, no sIC-mediated FcγRIIIA/CD16A activation could be detected in the serum of COVID-19 Vaxzevria/Spikevax or Comirnaty vaccine recipients (Fig. 4g). The gene discussed is FCGR3A; the disease is COVID-19.